03-29977. Manufacturer of Controlled Substances; Notice of Registration  

  • Start Preamble

    By Notice dated August 19, 2003, and published in the Federal Register on September 2, 2003, (68 FR 52224), Cambridge Isotope Laboratories, Inc., 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

    DrugSchedule
    Methaqualone (2565)I
    Dimethyltryptamine (7435I
    Amphetamine (1100)II
    Methamphetamine (1105)II
    Pentobarbital (2270)II
    Secobartbital (2315)II
    Phencyclidine (7471)II
    Cocaine (9041)II
    Codeine (9050)II
    Oxycodone (9143)II
    Hydromorphone (9150)II
    Benzoylecgonine (9180)II
    Methadone (9250)II
    Dextropropoxyphene (9273)II
    Morphine (9300)II
    Fentanyl (9801)II

    The firm plans to manufacture small quantities of the listed controlled substances to produce isotope labeled standards for drug analysis.

    No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Cambridge Isotope Laboratories, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Cambridge Isotope Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. this investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Start Printed Page 67475Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed is granted.

    Start Signature

    Dated: November 19, 2003.

    Laura M. Nagel,

    Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

    End Signature End Preamble

    [FR Doc. 03-29977 Filed 12-1-03; 8:45 am]

    BILLING CODE 4410-09-M

Document Information

Published:
12/02/2003
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
03-29977
Pages:
67474-67475 (2 pages)
PDF File:
03-29977.pdf